NEW YORK (GenomeWeb News) – Pharmacogenomics firm Genomas today announced it has obtained clinical laboratory licenses from New York, Florida, and California.

The company's Laboratory of Personalized Health received CLIA certification in 2005, the same year the lab received licensure from Connecticut.

Last year, Genomas was credentialed as a Medicare provider and began providing services in Texas and Pennsylvania.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.